c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Research

• Publication date

  2013-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-13-0576PMID 24008320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression

  2013cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012cited by this paper
• Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice.

  2012cited by this paper
• MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits

  2012cited by this paper
• Stem cell factor receptor/c-Kit: from basic science to clinical implications.

  2012cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• Apoptotic effect of imatinib on human colon adenocarcinoma cells: influence on actin cytoskeleton organization and cell migration.

  2011cited by this paper
• A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro

  2011cited by this paper
• Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview.

  2011cited by this paper
• Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells

  2010cited by this paper
• Sp 1 / NF k B / HDAC / miR-29 b Regulatory Network in KIT-Driven Myeloid Leukemia

  2010cited by this paper
• Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

  2010cited by this paper
• Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

  2010cited by this paper
• Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes

  2010cited by this paper
• Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas

  2010cited by this paper
• c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis

  2010cited by this paper
• Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

  2009cited by this paper
• c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Regulation of Sp1 by cell cycle related proteins

  2008cited by this paper
• A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments

  2008cited by this paper
• Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats

  2008cited by this paper
• Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

  2007cited by this paper
• The many ways of Wnt in cancer.

  2007cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression

  2006cited by this paper
• A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer

  2006cited by this paper
• Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Wnt/beta-catenin signaling in development and disease.

  2006cited by this paper
• L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

  2005cited by this paper
• Faster cyclic loess: normalizing RNA arrays via linear models

  2004cited by this paper
• Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients

  2004cited by this paper
• The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.

  2002cited by this paper
• Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma.

  2002cited by this paper
• The cadherin-catenin adhesion system in signaling and cancer.

  2002cited by this paper
• Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.

  2002cited by this paper
• Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.

  2001cited by this paper
• Lack of expression of c‐KIT in ovarian cancers is associated with poor prognosis

  2000cited by this paper
• Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility

  2000cited by this paper
• Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis

  1998cited by this paper
• Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.

  1997cited by this paper
• Growth stimulation of colorectal carcinoma cells via the c‐kit receptor is inhibited by TGF‐β1

  1997cited by this paper
• Expression and identification of aberrant c-kit transcripts in human cancer cells.

  1997cited by this paper
• Differential roles of PI3‐kinase and Kit tyrosine 821 in Kit receptor‐mediated proliferation, survival and cell adhesion in mast cells.

  1995cited by this paper
• Pregnancy: The expression of c-kit protein in human adult and fetal tissues

  1993cited by this paper
• Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.

  1992cited by this paper

• Plasticity in cell adhesion during tumor progression.

  2025cites this paper
• c-Kit+ cells that intercalate with crypt Lgr5+ cells are distinctively multipotent in colonic epithelium renewal and repair

  2025cites this paper
• A Necessary Role for Cyclin D2 Induction During Colon Cancer Progression Mediated by L1

  2024cites this paper
• An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1

  2023cites this paper
• FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer

  2022cites this paper
• Downregulation of the Tumor Suppressor TFF1 Is Required during Induction of Colon Cancer Progression by L1

  2022cites this paper
• Role and regulation of autophagy in cancer.

  2022cites this paper
• Protein Kinase D–Dependent Downregulation of Immediate Early Genes through Class IIA Histone Deacetylases in Acute Lymphoblastic Leukemia

  2021cites this paper
• Winnie-APCMin/+ Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation

  2020cites this paper
• Winnie- APC Min /+ Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation

  2020cites this paper
• Wnt/β-Catenin Target Genes in Colon Cancer Metastasis: The Special Case of L1CAM

  2020influential citation
• Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer

  2020cites this paper
• Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt/β-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma

  2020cites this paper
• Expression, Purification, and Protease Activity of Helicobacter pylori HtrA in Escherichia coli

  2020cites this paper
• Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase

  2020cites this paper
• Increased expression of cathepsin D is required for L1-mediated colon cancer progression

  2019cites this paper
• Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape

  2019cites this paper
• ISG15 induction is required during L1-mediated colon cancer progression and metastasis

  2019cites this paper
• The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.

  2018cites this paper
• Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer

  2018cites this paper
• MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases.

  2018cites this paper
• Hypoxia and Selective Autophagy in Cancer Development and Therapy

  2018cites this paper
• Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer

  2018cites this paper
• A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10

  2017cites this paper
• Premature remodeling of fat body and fat mobilization triggered by platelet‐derived growth factor/VEGF receptor in Drosophila

  2017cites this paper
• Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine

  2017cites this paper
• Specificity protein 1: Its role in colorectal cancer progression and metastasis.

  2017cites this paper
• Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples

  2017cites this paper
• Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression

  2016cites this paper
• L1 cell adhesion molecule as a therapeutic target in cancer

  2016cites this paper
• Expert Review of Anticancer Therapy DOI : 10 . 1586 / 14737140 . 2016 . 1143363 Review L 1 cell adhesion molecule as a therapeutic target in cancer

  2016cites this paper
• The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis

  2016cites this paper
• Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis

  2015cites this paper
• Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting KIT

  2015cites this paper
• Alterations of the apical junctional complex and actin cytoskeleton and their role in colorectal cancer progression

  2015cites this paper
• CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival

  2015cites this paper
• c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer.

  2015cites this paper
• Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review

  2014cites this paper